Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-11

Clinical Trial Update: A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of ABT-122 in combination with methotrexate in patients with active rheumatoid arthritis who had an inadequat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABT-122
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2016-11-11